Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. SPY
2. PATH
3. KBH
4. AZO
5. USO
6. QQQ
7. ORCL
8. RCL
9. ONON
10. PLTR

Go back to Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device
(NASDAQ: FEMY) Delayed: 2.58 +0.02 (0.78%)
Previous Close $2.56    52 Week High $ 
Open $2.60    52 Week Low $ 
Day High $2.60    P/E N/A 
Day Low $2.50    EPS $ 
Volume 34,125